13F filing recap · Q2 2005
What did Lone Pine Capital buy in Q2 2005?
Reported stock-position changes between this filing and the previous one.
Stock value
$8.00B
Positions
58
Estimated turnover
31.6%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
AAPAdvance Auto Parts, Inc.$150.77Mreported value+2.34M sharesDNAGenentech Inc$142.96Mreported value+1.78M sharesMONMonsanto Company$125.13Mreported value+1.99M sharesPAPanamsat Holding Corporation$79.31Mreported value+3.87M sharesRCLRoyal Caribbean Cruises Ltd$59.16Mreported value+1.22M sharesSCHWSchwab Charles Corp$58.32Mreported value+5.17M sharesCMECme Group Inc$43.53Mreported value+147.3K sharesMRXMedicis Pharmaceutical Corporation$40.88Mreported value+1.29M sharesNTESNetease, Inc.$40.51Mreported value+709.3K sharesSRXSra International Inc$23.73Mreported value+683.4K sharesCONRConor Medsystems Inc$5.42Mreported value+353.4K shares